BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 24860095)

  • 1. Mouse models for studying the formation and propagation of prions.
    Watts JC; Prusiner SB
    J Biol Chem; 2014 Jul; 289(29):19841-9. PubMed ID: 24860095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Carlson GA; Prusiner SB
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prions and prion-like proteins.
    Fraser PE
    J Biol Chem; 2014 Jul; 289(29):19839-40. PubMed ID: 24860092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
    Goedert M
    Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration. Could they all be prion diseases?
    Miller G
    Science; 2009 Dec; 326(5958):1337-9. PubMed ID: 19965731
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.
    Jucker M; Walker LC
    Nature; 2013 Sep; 501(7465):45-51. PubMed ID: 24005412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The red-hot debate about transmissible Alzheimer's.
    Abbott A
    Nature; 2016 Mar; 531(7594):294-7. PubMed ID: 26983522
    [No Abstract]   [Full Text] [Related]  

  • 12. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.
    Holmes BB; Diamond MI
    J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Models for the Study of Prions.
    Holmes BB; Diamond MI
    Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27815306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding spectrum of prion diseases.
    Ayers JI; Paras NA; Prusiner SB
    Emerg Top Life Sci; 2020 Sep; 4(2):155-167. PubMed ID: 32803268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
    Wagner J; Ryazanov S; Leonov A; Levin J; Shi S; Schmidt F; Prix C; Pan-Montojo F; Bertsch U; Mitteregger-Kretzschmar G; Geissen M; Eiden M; Leidel F; Hirschberger T; Deeg AA; Krauth JJ; Zinth W; Tavan P; Pilger J; Zweckstetter M; Frank T; Bähr M; Weishaupt JH; Uhr M; Urlaub H; Teichmann U; Samwer M; Bötzel K; Groschup M; Kretzschmar H; Griesinger C; Giese A
    Acta Neuropathol; 2013 Jun; 125(6):795-813. PubMed ID: 23604588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion-like mechanisms in neurodegenerative diseases.
    Frost B; Diamond MI
    Nat Rev Neurosci; 2010 Mar; 11(3):155-9. PubMed ID: 20029438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion-like disorders: blurring the divide between transmissibility and infectivity.
    Cushman M; Johnson BS; King OD; Gitler AD; Shorter J
    J Cell Sci; 2010 Apr; 123(Pt 8):1191-201. PubMed ID: 20356930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of crowded physiological environments in prion and prion-like protein aggregation.
    Ma Q; Hu JY; Chen J; Liang Y
    Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
    Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
    J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.